Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | SS31@LNP-PCM, SS31 peptide @lipid nanoparticles-phase change material |
| Catalog Number | R-LNP-SP |
| Alias | SS31 peptide-loaded lipid nanoparticle-phase change material composite |
| Appearance | Suspension |
| Molecular Formula | N/A |
| Solubility | Stably dispersed in water and physiological buffers |
| Storage | 2-8°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | drug delivery |
| Specification | 10mg:Inquiry 20mg:Inquiry 50mg:Inquiry |
| Description | SS31 peptide @LNP-PCM is a composite nano-delivery system integrating targeting and controlled release, consisting of SS31 peptide, lipid nanoparticles (LNP) and phase change materials (PCM). SS31 peptide is a small molecule peptide with mitochondrial targeting ability that can specifically bind to receptors on the mitochondrial membrane. LNP serves as a carrier skeleton and uses an amphipathic structure to wrap the SS31 peptide to improve its stability and cell penetration. The introduction of PCM gives the system temperature responsiveness and phase changes at specific temperatures to achieve controlled release of the drug. This system combines the targeting accuracy of peptides, the biocompatibility of LNP, and the intelligent drug release characteristics of PCM. It can reduce the degradation of SS31 peptide in the body, improve its delivery efficiency to mitochondria, and provides a delivery platform for the treatment of mitochondria-related diseases. |